» Authors » Hiroshi Kawachi

Hiroshi Kawachi

Explore the profile of Hiroshi Kawachi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 284
Citations 3968
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakano K, Hirasawa T, Takasu A, Higashi Y, Nunobe S, Shimoda M, et al.
Digestion . 2025 Mar; :1-23. PMID: 40058358
Introduction: Autoimmune gastritis (AIG), a type of chronic atrophic gastritis, is characterized by positive anti-parietal cell antibodies and mucosal atrophy predominantly in the corpus. In Japan, AIG has garnered increasing...
2.
Tamaru Y, Kuwai T, Kajiwara Y, Oka S, Saito S, Fukunaga Y, et al.
Am J Gastroenterol . 2025 Mar; PMID: 40029076
No abstract available.
3.
Noguchi T, Akiyoshi T, Sakamoto T, Matsui S, Mukai T, Yamaguchi T, et al.
Dis Colon Rectum . 2025 Feb; 68(3):316-326. PMID: 39977592
Background: There is a lack of consensus regarding treating involved lateral pelvic lymph nodes in rectal cancer. Objective: This study aimed to evaluate the clinical and MRI-based factors associated with...
4.
Sakamoto T, Mukai T, Noguchi T, Matsui S, Yamaguchi T, Akiyoshi T, et al.
Surg Today . 2025 Jan; PMID: 39888401
Purpose: The pattern of lymph node metastasis and the appropriate extent of lymph node dissection in splenic flexure colon cancer remain unclear. This study aimed to describe the clinical characteristics,...
5.
Sano S, Akiyoshi T, Yamamoto N, Noguchi T, Sakamoto T, Matsui S, et al.
Dis Colon Rectum . 2024 Dec; 68(3):327-337. PMID: 39625404
Background: Desmoplastic reaction is recognized as a prognostic factor in colorectal cancer. However, its significance in locally advanced rectal cancer after neoadjuvant chemoradiotherapy remains underexplored. Objective: To assess the prognostic...
6.
Ishihara R, Kawachi H, Nakano K, Kadota T, Matsuno K, Takizawa A, et al.
J Gastroenterol . 2024 Nov; 60(2):131-140. PMID: 39589535
Background: Esophageal cancer is a major cause of cancer mortality worldwide. Endoscopic resection (ER) is a curative treatment for esophageal squamous cell carcinoma (ESCC). Predicting risk of metastasis is crucial...
7.
Shimizu R, Yoshio T, Hijikata K, Ishiyama A, Ikenoyama Y, Namikawa K, et al.
Esophagus . 2024 Nov; 22(1):115-123. PMID: 39543070
Background And Study Aim: Endoscopic resection (ER) of esophageal squamous cell carcinoma (ESCC) is an organ-preserving treatment; however, heterochronic carcinomas are often encountered. Most patients are treated using ER; however,...
8.
Tomaru S, Takeuchi Y, Koike M, Ikota H, Mukai T, Kawachi H, et al.
Gastrointest Endosc . 2024 Oct; 101(3):683-685. PMID: 39424006
No abstract available.
9.
Sato N, Ono S, Kamiya K, Uesugi N, Fujishima F, Kawachi H, et al.
Pathol Res Pract . 2024 Oct; 263:155621. PMID: 39362134
Tumors related to the gut-associated lymphoid tissue (GALT) have been recently described. GALT carcinomas (GCs) have a characteristic appearance: macroscopically, they appear as a "dome-type" lesion, whereas microscopically, they show...
10.
Fujioka K, Nagai T, Hattori T, Kagami S, Yasutomo K, Galjart N, et al.
Nephrology (Carlton) . 2024 Oct; 29(12):815-824. PMID: 39350520
Aim: Several studies have shown that the progression of proteinuria and renal tissue injury is associated with activation of the intrarenal renin-angiotensin system (RAS). CCCTC-binding factor (CTCF) is a DNA-binding...